LTFS
AGRX

Ladenburg Thalmann Financial Services’s Agile Therapeutics AGRX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Buy
+1
New +$3.49K ﹤0.01% 5005
2015
Q4 		– Sell
-1
Closed -$10K – 4821
2015
Q3 		$10K Hold
1
– – ﹤0.01% 3553
2015
Q2 		$21K Hold
1
– – ﹤0.01% 3215
2015
Q1 		$14K Hold
1
– – ﹤0.01% 3426
2014
Q4 		$9K Hold
1
– – ﹤0.01% 3486
2014
Q3 		$9K Sell
1
-1
-50% -$15.4K ﹤0.01% 3178
2014
Q2 		$33K Buy
+2
New +$28.9K ﹤0.01% 2302

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AGRX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Agile Therapeutics (AGRX) in Q4 2019: 1 share worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #5005 among its holdings. This is a return to the name: Ladenburg Thalmann Financial Services previously reported a position in AGRX as recently as Q3 2015.

Ladenburg Thalmann Financial Services first reported a position in AGRX in Q2 2014 and has held it in 7 quarters since. The position peaked at $33K in Q2 2014. 46 funds tracked by Wall St. Rank hold AGRX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1 share of Agile Therapeutics worth $3K as of Q4 2019.
  • Agile Therapeutics was a new Ladenburg Thalmann Financial Services position in Q4 2019.
  • Agile Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5005 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Agile Therapeutics in Q2 2014 and has held it in 7 quarters since.
  • Ladenburg Thalmann Financial Services's Agile Therapeutics position peaked at $33K in Q2 2014.
  • 46 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.